title: Factors Associated with Influenza Vaccination of Hospitalized Elderly Patients in Spain.
abstract: Vaccination of the elderly is an important factor in limiting the impact of influenza in the community. The aim of this study was to investigate the factors associated with influenza vaccination coverage in hospitalized patients aged ≥ 65 years hospitalized due to causes unrelated to influenza in Spain. We carried out a cross-sectional study. Bivariate analysis was performed comparing vaccinated and unvaccinated patients, taking in to account sociodemographic variables and medical risk conditions. Multivariate analysis was performed using multilevel regression models. We included 1038 patients: 602 (58%) had received the influenza vaccine in the 2013-14 season. Three or more general practitioner visits (OR = 1.61; 95% CI 1.19-2.18); influenza vaccination in any of the 3 previous seasons (OR = 13.57; 95% CI 9.45-19.48); and 23-valent pneumococcal polysaccharide vaccination (OR = 1.97; 95% CI 1.38-2.80) were associated with receiving the influenza vaccine. Vaccination coverage of hospitalized elderly people is low in Spain and some predisposing characteristics influence vaccination coverage. Healthcare workers should take these characteristics into account and be encouraged to proactively propose influenza vaccination to all patients aged ≥ 65 years.
authors.affiliation: Departament de Salut Pública, Universitat de Barcelona, Barcelona, Spain.|CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
authors.forename: Àngela
authors.initials: À
authors.lastname: Domínguez
authors.affiliation: CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
authors.forename: Núria
authors.initials: N
authors.lastname: Soldevila
authors.affiliation: Departament de Salut Pública, Universitat de Barcelona, Barcelona, Spain.
authors.forename: Diana
authors.initials: D
authors.lastname: Toledo
authors.affiliation: CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.|Agència de Salut Pública de Catalunya, Barcelona, Spain.|Institut de Recerca Biomèdica de Lleida, Universitat de Lleida, Lleida, Spain.
authors.forename: Pere
authors.initials: P
authors.lastname: Godoy
authors.affiliation: CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.|Instituto de Salud Pública, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.
authors.forename: Jesús
authors.initials: J
authors.lastname: Castilla
authors.affiliation: Hospital de Mataró, Mataró, Spain.
authors.forename: Lluís
authors.initials: L
authors.lastname: Force
authors.affiliation: CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.|Universitat de Valencia, Valencia, Spain.
authors.forename: María
authors.initials: M
authors.lastname: Morales
authors.affiliation: Servicio de Vigilancia de Andalucía, Sevilla, Spain.
authors.forename: José María
authors.initials: JM
authors.lastname: Mayoral
authors.affiliation: Hospital de Galdakao, Usansolo, Spain.
authors.forename: Mikel
authors.initials: M
authors.lastname: Egurrola
authors.affiliation: Dirección General de Salud Pública, Investigación, Desarrollo e Innovación, Junta de Castilla y León, León, Spain.
authors.forename: Sonia
authors.initials: S
authors.lastname: Tamames
authors.affiliation: Universidad de León, León, Spain.
authors.forename: Vicente
authors.initials: V
authors.lastname: Martín
authors.affiliation: Consejería de Sanidad, Madrid, Spain.
authors.forename: Jenaro
authors.initials: J
authors.lastname: Astray
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D009980:Influenza A virus / Q000276:immunology; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D007297:Inpatients / Q000523:psychology; D008297:Male; D017533:Marital Status / Q000706:statistics & numerical data; D010353:Patient Education as Topic; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D011018:Pneumonia, Pneumococcal / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D012923:Social Class; D013030:Spain; D013296:Streptococcus pneumoniae / Q000276:immunology; D014611:Vaccination / Q000523:psychology / Q000706:statistics & numerical data*
chemical_list: D007252:Influenza Vaccines; D022242:Pneumococcal Vaccines
references.citation: PLoS One. 2011;6(7):e22618
references.pmid: 21818350
references.citation: J Health Soc Behav. 1995 Mar;36(1):1-10
references.pmid: 7738325
references.citation: PLoS One. 2013 Oct 16;8(10):e76318
references.pmid: 24146855
references.citation: J Infect Dis. 2010 Jan 15;201(2):186-9
references.pmid: 19995265
references.citation: Lancet. 2008 Aug 2;372(9636):398-405
references.pmid: 18675690
references.citation: Int J Infect Dis. 2013 Dec;17(12):e1194-7
references.pmid: 24084246
references.citation: Public Health. 2004 Dec;118(8):582-7
references.pmid: 15530939
references.citation: Vaccine. 2008 Mar 10;26(11):1432-7
references.pmid: 18272261
references.citation: Cochrane Database Syst Rev. 2010 Feb 17;(2):CD004876
references.pmid: 20166072
references.citation: Int J Nurs Stud. 2009 Jun;46(6):768-77
references.pmid: 19162264
references.citation: Euro Surveill. 2012 Apr 26;17(17):
references.pmid: 22551499
references.citation: Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76
references.pmid: 23210147
references.citation: MMWR Morb Mortal Wkly Rep. 2014 Dec 12;63(49):1151-4
references.pmid: 25503917
references.citation: Age Ageing. 2011 Jan;40(1):35-41
references.pmid: 21148323
references.citation: Cad Saude Publica. 2012 May;28(5):878-88
references.pmid: 22641511
references.citation: BMC Public Health. 2011 Apr 01;11:207
references.pmid: 21457562
references.citation: BMC Public Health. 2013 Mar 20;13:246
references.pmid: 23514534
references.citation: Vaccine. 2006 Jan 30;24(5):622-8
references.pmid: 16169638
references.citation: Rev Esp Salud Publica. 2002 Jan-Feb;76(1):17-26
references.pmid: 11905396
references.citation: J Infect Dis. 2001 Sep 15;184(6):665-70
references.pmid: 11517426
references.citation: Prev Med. 2013 May;56(5):337-40
references.pmid: 23402962
references.citation: BMJ. 2004 Sep 18;329(7467):660
references.pmid: 15313884
references.citation: Milbank Mem Fund Q Health Soc. 1973 Winter;51(1):95-124
references.pmid: 4198894
references.citation: Vaccine. 2014 Dec 5;32(51):6884-6901
references.pmid: 25454864
references.citation: Lancet Infect Dis. 2007 Oct;7(10):658-66
references.pmid: 17897608
references.citation: Infection. 2009 Oct;37(5):390-400
references.pmid: 19768382
references.citation: Lancet Infect Dis. 2012 Jan;12(1):36-44
references.pmid: 22032844
references.citation: BMC Public Health. 2013 Apr 25;13:388
references.pmid: 23617788
references.citation: Epidemiol Rev. 2006;28:54-70
references.pmid: 16707648
references.citation: N Engl J Med. 2007 Oct 4;357(14):1373-81
references.pmid: 17914038
references.citation: Vaccine. 2009 Jun 19;27(30):4018-24
references.pmid: 19389442
references.citation: Vaccine. 2011 Jun 15;29(27):4492-8
references.pmid: 21545822
references.citation: Wien Med Wochenschr. 2008;158(19-20):583-8
references.pmid: 18998078
references.citation: BMC Fam Pract. 2015 Mar 31;16:44
references.pmid: 25880501